| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/05/2006 | EP0862453B1 Bone morphogenetic protein and fibroblast growth factor compositions and methods for the induction of cardiogenesis |
| 04/05/2006 | EP0784486B1 Interleukin-12 as an adjuvant for paramyxoviridae vaccines |
| 04/05/2006 | EP0772773B1 Src SH3 BINDING PEPTIDES AND METHODS OF ISOLATING AND USING SAME |
| 04/05/2006 | EP0618965B1 Method for generating structural and functional diversity in a peptide sequence |
| 04/05/2006 | CN1756842A Branched neutral amino acid transporters acting as single molecule |
| 04/05/2006 | CN1756839A Method to increase fibronectin |
| 04/05/2006 | CN1756838A Secreted polypeptide species (fragments from chitotriosidase) reduced in cardiovascular disorders |
| 04/05/2006 | CN1756765A Metastin derivatives and their use |
| 04/05/2006 | CN1756587A Use of recombinant albumin in dialysis after liver failure |
| 04/05/2006 | CN1756569A P53 treatment of papillomarivus and carcinogen-transformed cells in hyperplastic lesions |
| 04/05/2006 | CN1756566A Use of the corticoliberin-urocortin system in the treatment of inflammatory diseases |
| 04/05/2006 | CN1756560A Complement receptor 2 targeted complement modulators |
| 04/05/2006 | CN1756559A Stabilized aqueous compositions comprising tissue factor pathway inhibitor (TFPI) or tissue factor pathway inhibitor variant |
| 04/05/2006 | CN1756558A Combination therapy for treating protein deficiency disorders |
| 04/05/2006 | CN1756557A Sincalide formulations |
| 04/05/2006 | CN1756556A Methods of treating neurological conditions with hematopoeitic growth factors |
| 04/05/2006 | CN1754889A Pegylated interferon alpha-1b |
| 04/05/2006 | CN1754886A Blood platelet reinforcing protein and application thereof |
| 04/05/2006 | CN1754575A Oral insulin protecting agent |
| 04/05/2006 | CN1754573A Use of immunoglobulin and cell growth factor in preparing medicine for asthma |
| 04/05/2006 | CN1754572A Slow release microphere for injection containing interferon alpha-1b and its preparation method |
| 04/05/2006 | CN1754571A Slow release microphere for injection containing interferon alpha-2b and its preparation method |
| 04/05/2006 | CN1754570A Slow release microphere for injection containing interferon or its analog and its preparation method |
| 04/05/2006 | CN1754569A Use of polyproline polypeptide in preparing medicine for treating malignant tumour |
| 04/05/2006 | CN1754568A Artificial hymen |
| 04/05/2006 | CN1249233C Surface proteins of chlamydia pneumoniae |
| 04/05/2006 | CN1249231C Actinia neurotoxin gene and its application |
| 04/05/2006 | CN1249229C Soluble T cell receptor |
| 04/05/2006 | CN1249227C 真菌细胞壁合成基因 Fungal cell wall synthesis genes |
| 04/05/2006 | CN1249225C Preparation and application of recombined human betaine homocysteine methyl transferase |
| 04/05/2006 | CN1249224C 超氧化物歧化酶组合物及其制备方法 Superoxide dismutase composition and its preparation method |
| 04/05/2006 | CN1249091C Fibre containing composition for enteral nutrition |
| 04/05/2006 | CN1249088C Antitumour medicine containing recombinant bacterial toxin protein complex substance |
| 04/05/2006 | CN1249087C Novel human G-Protein coupled receptor |
| 04/05/2006 | CN1249086C Melanocortin receptor ligands |
| 04/05/2006 | CN1249085C Immunogenic but non-amyloidogenic synthetic peptides homologous to beta amyloid for induction of immune response to beta amyloid and amyloid deposits |
| 04/05/2006 | CN1249083C Polypeptide drug for inhibiting SARS coronavirus from infecting host cell |
| 04/05/2006 | CN1249082C Apoptosis promoting gene BNIPL, coding albumen and uses thereof |
| 04/05/2006 | CN1249081C Glycopeptide derivatives and pharmaceutical compositions containing same |
| 04/05/2006 | CN1248736C 疫苗组合物 Vaccine compositions |
| 04/05/2006 | CN1248735C Preparing method and usage of cardiotoxin |
| 04/05/2006 | CN1248734C Matrix protein compositions for wound healing |
| 04/05/2006 | CN1248733C Tie2 receptor-induced gene transfer system for treating target tumor genes |
| 04/05/2006 | CN1248732C Embonate medicine composition containing bombesin-like product |
| 04/05/2006 | CN1248731C Combined application of tumor suppressor gene therapy and chemotherapy in preparation of pharmaceutical composition for treating tumor |
| 04/05/2006 | CN1248671C Use of 3-position cyclosporin derivatives for hair growth |
| 04/04/2006 | USRE39055 Hepatoselective pharmaceutical actives |
| 04/04/2006 | US7022831 anticode oligomer treatments for inhibiting growth of cancer cells; complementary to mRNA |
| 04/04/2006 | US7022830 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 04/04/2006 | US7022828 Anticancer agents, antiinflammatory agents, autoimmune disease; modulation of gene expression; nuclear factor kappa B |
| 04/04/2006 | US7022822 Purification process for obtaining the human urinary gonadotropins follicle-stimulating hormone (FSH) and/or luteinizing hormone (LH) using ion exchange resins; obtained FSH and LH are absolutely free of foreign contaminants derived from the use of biological reagents or chromatography dyes |
| 04/04/2006 | US7022820 Nucleotide sequences for use in the treatment and detection of tumor disorders |
| 04/04/2006 | US7022818 of given amino acid sequence; use as a target for drug screening of antagonists or agonists of said receptor; receptor can bind persephin |
| 04/04/2006 | US7022816 Dopamine receptors and genes |
| 04/04/2006 | US7022815 truncated derivatives of PTH; have one of the following key substitutions: Ser3 --> Ala, Asn10 --> Ala or Gln; Leu11 --> Arg, Gly12 --> Ala and His14 --> Trp; use to treat bone disorders such as osteoporosis |
| 04/04/2006 | US7022738 (3S)-N-butyl-3-((2S)-2-(((4-fluorophenyl)sulfonyl)amino)-3-methylbutanoylamino)-5-methyl-2-oxohexanamide; calpain inhibition; Alzheimer's, osteoporosis, brain and eye disorders, ischemia |
| 04/04/2006 | US7022693 Treatment of lipodystrophy |
| 04/04/2006 | US7022677 such as N-(3-Amino-2-hydroxypropyl)-2(R)-[1-(2-ethylbutyryl)pyrrolidine-2(S)-carbonyl-amino]-3-naphthalen-2-yl-propionamide hydrochloride; for increasing milk and wool production in animals |
| 04/04/2006 | US7022676 obtained by hydrolysis of casein; hypotensive agentsl; for use in foods and drugs |
| 04/04/2006 | US7022675 Administering angiotensin ii |
| 04/04/2006 | US7022674 Polypeptide compositions with improved stability |
| 04/04/2006 | US7022673 Generation of biocompatible active macromolecules with amplified half-life; obtain macromolecule, couple to polymer, recover macromolecule |
| 04/04/2006 | US7022672 Formulation, solubilization, purification, and refolding of tissue factor pathway inhibitor |
| 04/04/2006 | US7022671 Surfactant protein C esters |
| 04/04/2006 | US7022670 nerve growth factors; for activating tyrosine kinase receptors |
| 04/04/2006 | US7022669 such as 1-[4-[[(1H-benzimidazol-2-yl)-methyl]-amino]-N2-[[4'-(pentyloxy) [1,1':4', 1'' terphenyl]-4-yl]-carbonyl]-L-ornithine]-4-[4-(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandin B trifluoroacetate |
| 04/04/2006 | US7022668 improves adhesion of human dermal fibroblasts and promotes the cellular growth of human epidermal keratinocytes; produced by Pseudoalteromonas antartica; for topical or oral administration; veterinary medicine; for treatment of hair, skin, and nails |
| 04/04/2006 | US7022667 Mycobacterium; grampositive bacteria bactericides, antibiotics |
| 04/04/2006 | US7022666 administering leukemia inhibitory factor, and human cell growth factors such as tumor growth factors, fibroblast growth factors, and tissue inhibitors of metalloproease |
| 04/04/2006 | US7022521 Methods and compositions for treating platelet-related disorders using MPL pathway inhibitory agents |
| 04/04/2006 | US7022500 Humanized immunoglobulins |
| 04/04/2006 | US7022499 Nucleic acids encoding differentiation inhibitor delta 2 |
| 04/04/2006 | US7022489 Nucleotide sequences coding protein for use in the treatment of alzheimer's disease |
| 04/04/2006 | US7022485 immunogens or target antigens comprising citrullinated polypeptide derived from fragments of fibrinogen; prophylaxis of inflammatory disorders |
| 04/04/2006 | US7022482 Deactivation antigen protein; anticancer agents; Aids therapy |
| 04/04/2006 | US7022474 Nucleotide sequences coding polypeptide for use in tumor therapy |
| 04/04/2006 | US7022340 Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
| 04/04/2006 | US7022329 Using botulinum toxin |
| 04/04/2006 | US7022328 Therapeutic and diagnostic compositions |
| 04/04/2006 | US7022326 Carboxymethylated retroviral regulatory proteins and interferon-α |
| 04/04/2006 | US7022323 Prevent infections using envelope glycoprotein; binding to antibody |
| 04/04/2006 | US7022322 Comprises ligand for human immunoglobulin for immunoapheresis, which mimicks sequence of an adrenergic receptor structure |
| 04/04/2006 | US7022321 Use of marrow-derived glial progenitor cells as gene delivery vehicles into the central nervous system |
| 04/04/2006 | US7022319 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy |
| 04/04/2006 | US7022315 Administering a thiol-based chemoprotectant agent intra-arterially for therapy and prophylaxis of side effects of cytotoxic cancer therapy for tumors located in the brain, head or neck |
| 04/04/2006 | US7022313 Hydrogel particle formulation |
| 04/04/2006 | US7022309 Targeting molecule linked to an imaging agent |
| 04/04/2006 | US7021309 Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin |
| 04/04/2006 | CA2379521C Methods to identify compounds that modulate rage |
| 04/04/2006 | CA2120503C The regulation of systemic immune responses utilizing cytokines and antigens |
| 04/04/2006 | CA1341503C Molecular cloning and expression of human il-3 |
| 03/30/2006 | WO2006034507A2 Methods of diagnosing and treating complications of pregnancy |
| 03/30/2006 | WO2006034435A2 Methods and compositions for treating glucose-associated conditions, metabolic syndrome, dyslipidemias and other conditions |
| 03/30/2006 | WO2006034134A2 Antibacterial peptide with activity against b. anthracis |
| 03/30/2006 | WO2006034128A2 Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use |
| 03/30/2006 | WO2006034121A1 Methods and compositions for use of angiogenesis inhibitors in the prevention and/or control of epilepsy |
| 03/30/2006 | WO2006034106A2 Baff variants and methods therof |
| 03/30/2006 | WO2006034056A2 G-type peptides and other agents to ameliorate atherosclerosis and other pathologies |
| 03/30/2006 | WO2006034035A2 Treatment of ischemia |
| 03/30/2006 | WO2006034007A2 Methods of treating metabolic disorders by modulation of salt-inducible serine/threonine kinase 2 |